Prot# M-INTG03-062: Early Glycoprotein IIb/IIIa Inhibition in Non-ST Segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluation the Clinical Benefits of Early Front-Loaded Eptifibatied in the Treatment of Patients w/Non-S

Project: Research project

Project Details

StatusFinished
Effective start/end date3/16/053/1/12

Funding

  • Duke Clinical Research Institute (M-INTG03-062)
  • Millennium Pharmaceuticals, Inc (M-INTG03-062)